The growth pattern of transplanted normal and nodular hepatocytes by Doratiotto, Silvia et al.
ORIGINAL PAPER
The growth pattern of transplanted normal
and nodular hepatocytes
Silvia Doratiotto • Petra Krause • Maria Paola Serra •
Fabio Marongiu • Marcella Sini • Sarah Koenig •
Ezio Laconi
Accepted: 15 April 2011/Published online: 29 April 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Overt neoplasia is often the end result of a long
biological process beginning with the appearance of focal
lesions of altered tissue morphology. While the putative
clonal nature of focal lesions has often been emphasized,
increasing attention is being devoted to the possible role of
an altered growth pattern in the evolution of carcinogenesis.
Here we compare the growth patterns of normal and nodular
hepatocytes in a transplantation system that allows their
selective clonal proliferation in vivo. Rats were pre-treated
with retrorsine, which blocks the growth of resident hepa-
tocytes, and were then transplanted with hepatocytes iso-
lated from either normal liver or hepatocyte nodules. Both
cell types were able to proliferate extensively in the reci-
pient liver, as expected. However, their growth pattern was
remarkably different. Clusters of normal hepatocytes inte-
grated in the host liver, displaying a normal histology;
however, transplanted nodular hepatocytes formed new
hepatocyte nodules, with altered morphology and sharp
demarcation from surrounding host liver. Both the expres-
sion and distribution of proteins involved in cell polarity,
cell communication, and cell adhesion, including connexin
32, E-cadherin, and matrix metalloproteinase-2, were
altered in clusters of nodular hepatocytes. Furthermore, we
were able to show that down-regulation of connexin 32 and
E-cadherin in nodular hepatocyte clusters was independent
of growth rate. These results support the concept that a
dominant pathway towards neoplastic disease in several
organs involves defect(s) in tissue pattern formation.
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Introduction
Many human solid cancers, including hepatocellular car-
cinoma, often arise from discrete focal lesions that long
precede the overt clinical appearance of the disease. In fact,
it is well established that such lesions represent a common
precursor site for overt neoplasia (Clark et al. 1984; Foulds
1975; Hruban et al. 2000; Hytiroglou et al. 2007; Montironi
et al. 2002; Noffsinger 2009; Schreer and Lu ¨ttges 2005;
Su et al. 1997), thus implying that gaining insights into
their biology and pathogenesis bears direct relevance to our
understanding of the natural history of neoplastic disease.
Historically, the salient feature of cancer precursor
lesions has been considered to reside in their putative
clonal nature, and this notion still forms the basis for most
of the current theories on the pathogenesis of neoplastic
disease (Diallo et al. 2001; Garcia et al. 2000; Iannaccone
et al. 1987; Mason et al. 2010). Within this perspective,
research efforts continue to be focussed mainly on putative
biochemical and molecular changes of rare altered cells
that could possibly explain their selective growth, resulting
in the emergence of focal proliferative lesions (Hanahan
and Weinberg 2000).
However, over the past few years increasing attention
has been devoted to the analysis of the phenotypic property
S. Doratiotto and P. Krause contributed equally to this work.
S. Doratiotto   M. P. Serra   F. Marongiu   M. Sini  
E. Laconi (&)
Department of Biomedical Sciences and Biotechnology,
Section of Experimental Pathology, University of Cagliari,
Via Porcell, 4, 09125 Cagliari, Italy
e-mail: elaconi@unica.it
P. Krause   S. Koenig
Department of General Surgery, University Medical Centre
Goettingen, Go ¨ttingen, Germany
123
Histochem Cell Biol (2011) 135:581–591
DOI 10.1007/s00418-011-0813-3that serves to deﬁne these focal lesions, i.e. their altered
growth pattern. In fact, a nodule, an adenoma, a polyp or a
papilloma are deﬁned as discrete lesions displaying a
morphology distinct from that of the normal surrounding
counterpart. While this phenotypic feature has long been
neglected and implicitly considered as a mere by-product
of clonal growth, it is now emerging as a fundamental
property of pre-cancerous lesions with speciﬁc pathoge-
netic relevance to the process (Chen et al. 2009; Doratiotto
et al. 2009; Schmeichel et al. 1998).
Over the past several years, we have developed a model
of orthotopic hepatocyte transplantation wherein the
selective clonal expansion of both normal and nodular
hepatocytes can be achieved and analysed over time in an
in vivo system (Laconi and Laconi 2002). This transplan-
tation model is based on a pre-conditioning regimen, i.e.
exposure of the recipient animal to retrorsine (RS), a nat-
urally occurring alkaloid that induces a persistent block on
the endogenous hepatocyte cell cycle (Laconi et al. 1999).
It was observed that both normal and nodular hepatocytes
undergo clonal proliferation when injected into the liver of
RS-treated hosts. However, the biological outcome is rad-
ically different in either case. In fact, transplanted normal
hepatocytes integrate in the host liver and gradually
repopulate the entire organ with a seemingly normal his-
tology (Laconi et al. 2001b). In contrast, when hepatocytes
isolated from liver nodules are injected into RS-treated
animals, they also proliferate but fail to integrate in the host
parenchyma and rather undergo expansive growth, re-
forming liver nodules that rapidly progress to hepatocel-
lular carcinoma (Laconi et al. 2001a).
Thus,thissystemofferstheuniqueopportunitytocompare
twoclonallyexpanding cellpopulations,normalandnodular
hepatocytes, in vivo and possibly to dissect the biochemical
and/or molecular alterations critically relevant to their dif-
ferent phenotypic behaviour (Marongiu et al. 2008). In the
presentstudy,weanalysedthegrowthpatternoftransplanted
normal and nodular hepatocytes vis-a `-vis the expression of
proteins involved in cell polarity, cell migration, cell-to-cell
and cell-to-extracellular matrix adhesion, and communica-
tion, including connexin 32 (Cx32), E-cadherin, and matrix
metalloproteinase-2 (MMP-2). We observed that the altered
growth pattern of transplanted nodular hepatocytes is con-
sistently associated with decreased expression of Cx32,
E-cadherin, and MMP-2. Furthermore, it was unequivocally
foundthatthesealterationsareinherenttonodularlesionsand
are unrelated to growth per se.
Materials and methods
All animals were maintained on daily cycles of alternating
12 h light/darkness with food and water available
ad libitum. They were fed Purina Rodent Lab Chow diet
(Ditta Mucedola, Italy) throughout the experiment and
received humane care in accordance with the regulations
and criteria of the Animal Care Unit of the University of
Cagliari.
Induction of liver nodules in donor rats and isolation
of nodular and normal hepatocytes
Hepatocyte nodules were induced according to a well-
characterized experimental model in the rat, as previously
described (Laconi et al. 2001b) and nodule-bearing livers
were perfused according to a standard two-step collagenase
perfusion technique (Laconi et al. 2001a; Seglen 1976).
Large ([5 mm in diameter) nodules were physically sep-
arated from surrounding tissue and cells isolated from
nodular tissue were suspended in Williams E culture
medium (Sigma, cat No. W-4125) and prepared for trans-
plantation experiments. Cell viability, determined by try-
pan blue dye exclusion, was 80–85%. Normal hepatocytes
were isolated from a normal young adult syngeneic Fischer
344 donor rat following a similar two-step collagenase
perfusion technique. The isolated cell fraction used for
transplantation studies was judged to be *95% hepato-
cytes by morphological analysis and cell viability was
consistently [85%, as determined by trypan blue dye
exclusion. Aliquots of these cells were also used for PCR
analysis of MMP-2 RNA expression (see the following
paragraphs).
Treatment of recipient rats and transplantation
of hepatocytes
In order to follow the fate of donor hepatocytes in the
recipient liver, the dipeptidyl-peptidase type IV-deﬁcient
(DPPIV
-) rat model was used (Thompson et al. 1991). In
this system, cells isolated from a Fischer 344 rat expressing
DPPIV (DPPIV
?) are transplanted into a syngeneic
DPPIV
- recipient, such that cells derived from donors may
be detected in the host liver through simple (immuno-)
histochemical techniques. A colony of DPPIV
- F344 rats
has been established in the Department of Biomedical
Sciences and Technology, University of Cagliari. DPPIV
-
recipient rats were treated according to the RS-based pro-
tocol developed in our laboratories (Laconi and Laconi
2002). Brieﬂy, 24 DPPIV
- rats, with a body mass of
80–100 g, were given two injections of RS (from Sigma),
30 mg/kg each, i.p., 2 weeks apart. Two weeks after the
last injection, animals were divided into two groups (A and
B, of 12 animals each) and were infused with either cells
isolated from DPPIV
? hepatocyte nodules (groups A,) or
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? normal liver donor (groups B).
Cells were isolated as described above and were delivered
via portal vein infusion, suspended in 0.3 ml of Williams E
medium. Animals from the two groups were killed 1 month
after transplantation (Tx); livers were excised, cut into
1–2 mm thick slices and grossly examined for the presence
of hepatic nodules and/or any other visible lesions. Liver
samples taken from each liver were either ﬁxed in 10%
buffered formaldehyde for standard histological analysis
(H&E staining) or snap frozen. Histochemical determina-
tion of DPPIV enzyme activity was performed as described
(Laconi et al. 2001b).
Immunohistochemistry for Ki67, Cx32, and E-cadherin
was performed using speciﬁc monoclonal antibodies (anti-
Ki67 from Abcam, cat # 16667; anti-Cx32 from Zymed
Labs, cat # 34-5700, anti-E-cadherin from Santa Cruz, cat.
# sc-8426). Detection of primary antibodies was accom-
plished using the avidin/biotin peroxidase system (Vecta-
stain ABC kit; Vector Laboratories, Burlingame, CA).
Colocalization of DPPIV with Cx32 and MMP-2
Tissues were immunostained for the ﬁrst antigen [anti-
Cx32 (1:5,000) and anti-MMP-2 (1:100)] (Neomarkers
Asbach, Germany) using Alexa 488 conjugated goat anti-
rabbit or anti-mouse IgG (Molecular Probes Goettingen,
Germany) for ﬂuorescence detection (1:400, 1 h at RT) and
then further processed with the second immunostaining
protocol. After rehydration in Tris buffer, specimens were
blocked and subsequently incubated with the second pri-
mary antibody (anti-DPPIV, 1:100), rinsed with Tris buffer
and exposed to the second Alexa Fluor 568 goat anti-
mouse IgG2a (Molecular Probes Goettingen, Germany)
(1:400, 1 h at RT). Slides were ﬁnally covered with Vec-
tashield
 mounting medium with DAPI (1 ll/ml) (Vector
Laboratories, UK) to visualise cell nuclei. Negative con-
trols were carried out for each antibody by omitting the
primary antibody from the protocol. Multiple immuno-
ﬂuorescence-labelled specimens were serially excited and
observed with the TEXAS Red-, FITC- and UV-ﬁlter set
on an inverted confocal microscope (LEICA DM IRE2,
Bensheim, Germany). Pictures of each ﬁlter set were dig-
itally merged using layering technology software (Leica
FW 4000, Version 1.1).
RNA isolation and RT-PCR
Total RNA was isolated using TRIzol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol.
RNA integrity and purity were conﬁrmed by 1% agarose
gel electrophoresis and OD260/OD280 nm absorption ratio
[1.8. Two grams of DNase-I treated RNA of each sample
were reverse-transcribed using Promega reagents (Pro-
mega, Madison, WI). The resulting cDNA was analysed
by PCR using the following primers and conditions:
b2-microglobulin (FWD: 50-GTCGTGCTTGCCATTC
AGA-30; REV: 50-TGAAGAAGATGGTGTGCTCA-30; Ta:
48C; 30 cycles); MMP-2 (FWD: 50-TCCAGGAGCTCT
ATGGGCCCTC-30; REV: 50- GCAGCCCAGCCAGTCC
GATT-30; Ta:6 3 C; 40 cycles). PCR thermal proﬁle was as
follows: 95C for 2 min, then 95C for 30 s, Ta for 1 min,
72C for 1 min for an appropriate number of cycles, fol-
lowed by extension at 72C for 5 min. PCR products were
visualized by 2% agarose gel electrophoresis.
Results
The growth pattern of normal and nodular hepatocytes
Normal transplanted hepatocytes integrated well in the
recipient liver, forming clusters of irregular shape which
were macroscopically indistinguishable in the context of
the host tissue. No signs of compression of the sur-
rounding tissue were evident during the growth of normal
cells derived from donors. The distribution of DPPIV
enzyme activity displayed the typical chicken-wire pat-
tern, consistent with its normal bile canalicular location
(Fig. 1a, c).
However, the growth pattern of transplanted nodular
hepatocytes was remarkably different. These cells formed
focal lesions that were readily identiﬁable as greyish-
brown areas on macroscopic examination, ranging in size
from\1 to 3 mm in diameter, both on the liver surface and
on sectioning. These lesions were mostly round or oval in
shape and were sharply demarcated from the surrounding
host tissue (Fig. 1b, d). The latter displayed signs of
compression, as indicated by the presence of concentric
hepatocyte plates distributed around larger nodules
(Fig. 1f). Moreover, histochemical detection of DPPIV
conﬁrmed the altered polarity of nodular hepatocytes, with
no deﬁned pattern in the protein enzyme distribution
(Fig. 1b, d). Many cells in nodules expressed cytoplasmic
DPPIV activity with relatively scarce membrane localiza-
tion, which became even more evident on immunoﬂuo-
rescence examination (Fig. 1d).
The surface receptor CD44, which is normally found in
non-parenchymal liver cells and is up-regulated in different
types of cancers, including hepatocellular carcinoma (Yang
et al. 2010), was not expressed by nodular hepatocyte
clusters derived from transplanted cells (Fig. 1g, h). How-
ever, scattered CD44-positive cells were present both inside
nodules and in surrounding liver exposed to RS (Fig. 1h), as
already reported in the literature (Kon et al. 2009).
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and nodular hepatocytes
Connexins are the major proteins of gap junctions, which
serve to establish communication channels between adja-
cent cells. As such, they are involved in both tissue pattern
formation and maintenance of integrated cellular functions.
Small molecules (\1 kDa in size) can be exchanged
through gap junctions, thereby contributing to the
functional cooperation of cells within tissues (Vinken et al.
2008). Given their direct involvement in processes related
to tissue pattern formation and cell-to-cell communication,
we decided to compare the expression of Cx32, the major
gap junction protein present in the liver, in the expanding
clusters of normal and nodular transplanted hepatocytes.
As presented in Fig. 2, Cx32 was regularly found with
the typical punctuated pattern of distribution at the cell
membrane in small and larger clusters of transplanted
Fig. 1 Histochemical staining
for DPPIV enzyme activity
(orange-rust) in clusters of
normal (a) and nodular
(b) hepatocytes transplanted
into the liver of DPPIV-
deﬁcient host rats pre-treated
with RS. Immunoﬂuorescence
labelling for DPPIV expression
(red) in clusters of normal
(c) and nodular (d) hepatocytes
transplanted as above; DAPI
(blue) identiﬁes nuclei. Both
enzyme activity and protein
distribution were typically
associated with the cell
membrane in normal hepatocyte
clusters (a, c), while they were
irregular and diffuse to the
cytoplasm in the expanding
clusters of nodular hepatocytes
(b, d). e, f Two serial cryostat
sections of a nodular hepatocyte
cluster stained for DPPIV
expression (e, orange-rust) and
with standard H&E (f). Note the
presence of megalocytes in the
RS-treated surrounding liver
(upper-left). g, h Two serial
sections of a large nodular
hepatocyte cluster stained for
DPPIV (g) and for the presence
of CD44 marker (h); CD44-
positive non-parenchymal cells
are present inside the nodule,
while transplanted nodular
hepatocytes are negative
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hepatocyte clusters resulting from the transplantation of
isolated nodular cells, the expression of Cx32 was nearly
absent or greatly reduced (Fig. 2d–f, h).
Furthermore, low Cx32 levels were found in nodules
with high or low proliferative rates, as indicated by Ki67
labelling ranging from 2% (Fig. 3b) to 34% (Fig. 3f). In
contrast, clusters of normal transplanted hepatocytes with
high or low Ki67 labelling displayed a normal pattern of
Cx32 expression, comparable to or even higher than that of
the surrounding host tissue (Fig. 3g–h). No correlation
could therefore be established between Cx32 expression
and proliferative activity in nodular hepatocyte clusters.
The expression of E-cadherin in transplanted normal
and nodular hepatocytes
Another protein critically involved in the genesis and
maintenance of tissue architecture in the liver is E-cad-
herin. Cadherins constitute a superfamily of at least 80
members and are a major component of adherens junc-
tion, i.e. the zipper-like seals between adjacent cells.
Cadherin–catenin complexes are also at the crossroad of
cell signalling coupled with cell adhesion (van Roy and
Berx 2008). The epithelial E-cadherin is expressed in the
normal liver and is under dynamic regulation during
liver regeneration following partial hepatectomy (Monga
et al. 2001). In the present study, our aim was to com-
pare the levels of expression of E-cadherin in the
expanding clusters of transplanted normal and nodular
hepatocytes, in light of the phenotypic differences in
their growth pattern described above. The results
obtained are illustrated in Fig. 4. Clusters of transplanted
normal hepatocytes displayed a regular distribution of
E-cadherin in the cell membrane (Fig. 4a–d). However,
such regular distribution was completely abrogated in
nodular hepatocyte clusters (Fig. 4e–h). In fact, the latter
displayed an overall decrease and patchy staining of the
cell adhesion protein, in line with the altered morphology
of nodular lesions.
Fig. 2 Immunoﬂuorescence colocalization of DPPIV (red) and Cx32
(green) in clusters of normal (a, b, c, g) and nodular (d, e, f,
h) hepatocytes. a, d DPPIV only; b, e Cx32 staining only; c, f, g,
h staining for DPPIV and Cx32 were merged. Note the regular pattern
of expression of Cx32 in normal hepatocyte clusters (b, c, g), while
the gap junction protein is almost undetected in the donor-derived
nodular lesion (e, f, h). See ‘‘Materials and methods’’ for details
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and nodular hepatocytes
Matrix metalloproteinases (MMPs) are a family of enzymes
that can collectively degrade all components of the extra-
cellular matrix. They play fundamental roles in several
processes, including tissue remodelling, inﬂammation,
wound healing, ﬁbrosis, cell migration, and metastasis,
among others (Ellerbroek and Stack 1999). MMPs are syn-
thesized as pro-enzymes and are activated upon proteolytic
cleavage in the extracellular space (Montironi et al. 2002).
MMP-2, also known as gelatinase A, can degrade collagens,
gelatin, elastin, ﬁbronectin, laminins, and is possibly
involved in the activation of other MMPs, such as MMP-9
and MMP-13 (Fridman et al. 2009). In a previous study, it
was found that MMP-2 is expressed at the leading edge of
expanding clusters of transplanted normal hepatocytes
(Koenig et al. 2005). Given the postulated role of MMP-2 in
cell migration, we decided to analyse the pattern of distri-
bution of this enzyme in the expanding clusters of normal
and nodular cell populations. As illustrated in Fig. 5,a
positiveimmunoﬂuorescentsignalcorrespondingtoMMP-2
Fig. 3 Pairs of serial
sections stained for
immunohistochemical detection
of Cx32 (left panels, a, c, e, g,
punctuated blue spots) or Ki67
(right panels, b, d, f, h, intense
blue nuclei). b, d, f, g,
h Processed for DPPIV enzyme
activity. Note that different rates
of Ki67 labelling in nodular
hepatocyte clusters (b: 2%, d:
11%, f: 34%), are associated
with similar low levels of Cx32
expression (a, c, e). However,
signiﬁcant Ki67 labelling in
normal hepatocyte clusters
(h) is paired with normal
distribution of Cx32 gap
junction protein (g). See
‘‘Materials and methods’’ for
details
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normal transplanted hepatocytes and the surrounding host
liver (Fig. 5a–c), in agreement with previous ﬁndings
(Koenig et al. 2005). In addition, scattered MMP-2 activity
could alsobedetectedwithintheseclusters(Fig. 5g).Onthe
other hand, a sharp demarcation was readily apparent
betweenclustersoftransplantednodularhepatocytesandthe
positive immunostaining for MMP-2 (Fig. 5d–f). While the
protein was strongly expressed in the tissue surrounding
nodular lesions, MMP-2 activity was virtually absent within
nodular hepatocyte clusters (Fig. 5h).
Furthermore, we found that the expression of MMP-2
RNA was markedly decreased in nodular hepatocyte prep-
arations as compared to their normal counterparts (Fig. 6).
Fig. 4 Pairs of serial
sections stained for
immunohistochemical detection
of E-Cadherin (left panels, a, c,
e, g) or DPPIV enzyme activity
(right panels, b, d, f, h). c, d, g,
h Magniﬁcations of a, b, e, f,
respectively. While E-cadherin
expression was regularly found
(punctuated dark blue dots,
arrows) in clusters of
transplanted normal hepatocytes
(compare a vs. b and c vs. d,
dotted lines), immunostaining in
nodular hepatocyte clusters was
virtually undetected (compare
e vs. f and g vs. h), while
arrows in g indicate punctuated
expression of the protein in the
liver surrounding nodular
hepatocytes. See ‘‘Materials and
methods’’ for details
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In this study, we compare the growth pattern and the
expression of proteins involved in cell adhesion, to cell-to-
cell communication and cell migration in two different
populations of clonally expanding hepatocytes: namely,
hepatocytes isolated from a normal untreated liver and
hepatocytes isolated from carcinogen-induced liver nod-
ules. In a former study, we already observed that neither
cell type was able to proliferate to any signiﬁcant extent
upon transplantation into syngeneic, untreated normal hosts
(Laconi et al. 2001a). However, both normal and nodular
hepatocytes underwent selective clonal expansion follow-
ing injection into the liver of rats pre-treated with RS.
Furthermore, we observed that the biological outcome was
radically different following transplantation of either cell
type in RS-treated recipients, as expected (Laconi et al.
2001a, b). In fact, the selective proliferation of normal
transplanted hepatocytes resulted in liver repopulation,
reproducing a seemingly normal tissue architecture, with
no evidence of pre-neoplastic and/or neoplastic lesions
(Laconi et al. 2001b). In contrast, the transplantation of
nodular hepatocytes was consistently associated with their
failure to integrate in the host liver and the formation of
liver nodules. Moreover, such nodules had the potential to
progress to hepatocellular carcinoma (Laconi et al. 2001a),
as also conﬁrmed in this study (data not presented).
Fig. 5 Immunoﬂuorescence colocalization of DPPIV (red) and
MMP-2 (green) in clusters of normal (a, b, c, g) and nodular (d, e,
f, h). Normal hepatocyte clusters display decreased ﬂuorescence
staining for MMP-2 compared to surrounding host liver (a–c).
However, low levels of expression are detected (g). In contrast, no
MMP-2 protein is detectable inside nodular hepatocyte clusters, while
intense expression is noted in the surrounding liver (d, e, f, h). See
‘‘Materials and methods’’ for details
Fig. 6 Expression of MMP-2 RNA in normal and nodular hepatocyte
preparations. Triplicates of both cell preparations were processed.
A marked reduction in gene expression is evident in nodular cells
(upper lanes); in the lower lanes the expression of the beta-2-
microglobulin gene is presented for comparison. The experiment was
repeated twice with similar pattern of results. See ‘‘Materials and
methods’’ for details
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on the growth pattern of normal and nodular hepatocytes
transplanted into RS-treated host rats, taking advantage of
the fact that we could compare two rapidly expanding cell
populations under similar experimental conditions. As
expected, both cell types exhibited selective clonal prolif-
eration in the recipient liver. The distribution of DPPIV
enzyme activity was remarkably altered in nodular hepa-
tocyte clusters, as shown in Fig. 1. Aberrant expression of
this enzyme has been reported in different types of cancers,
including hepatocellular carcinoma (Stecca et al. 1997). It is
reasonable to hypothesize that the altered distribution of
DPPIV enzyme activity in the expanding nodular hepato-
cytes may reﬂect, at least in part, an altered polarity of these
cells. On the other hand, DPPIV has also been proposed as a
possible marker for early diagnosis of HCC in hepatitis C
virus-positive cirrhotic patients (Archer et al. 2009).
Low levels of Cx32 expression have long been reported
in early focal lesions developing during liver carcinogen-
esis in the rat (Krutovskikh et al. 1991). However, this
alteration was found to be reversibly associated with the
proliferative rate of individual foci (Neveu et al. 1994).
Furthermore, normal proliferating hepatocytes also express
Cx32 to a low extent (Kren et al. 1993; Yamamoto et al.
2005), questioning whether altered expression of this pro-
tein is a primary phenomenon in some nodular lesions or it
is rather a consequence of their increased growth rate
(Neveu et al. 1994). Our results provide unequivocal evi-
dence indicating that decreased Cx32 expression is in fact
an inherent property of nodular hepatocyte lesions, at least
under the experimental conditions of the present studies.
Clusters of clonally expanding normal hepatocytes, with a
Ki67 labelling index comparable to that of transplanted
nodular clusters, displayed normal levels of Cx32 protein,
while Cx32 expression was low in nodular lesions origi-
nating from transplanted cells, regardless of high or low
proliferative rate (Fig. 3).
A similar pattern of results was visible on analysis of the
expression of E-cadherin. While expanding clusters of
normal transplanted hepatocytes displayed a regular dis-
tribution of this membrane protein, focal lesions resulting
from transplantation of nodular hepatocytes demonstrated
low levels and altered localization of E-cadherin. Studies
on the expression of E-cadherin in human hepatocellular
carcinoma (HCC) have generated rather conﬂicting results.
Earlier reports described elevated levels of E-cadherin in
the majority of thin-trabecular HCC (Ihara et al. 1996).
More recently, decreased expression of E-cadherin was
included in a panel of 12 molecular alterations that sig-
niﬁcantly discriminate between dysplastic nodules and
early human HCC (Llovet et al. 2006). Consistent with the
latter ﬁnding, E-cadherin has also been proposed as a
marker in the differential diagnosis between adenoma and
HCC (Tretiakova et al. 2009). Importantly, our results
provide direct evidence that these alterations appear early
in the process and are independent of cell proliferation per
se. Thus, it is possible that the failure of nodular hepato-
cytes to integrate into the surrounding parenchyma is due,
at least in part, to the altered expression of proteins
involved in cell-to-cell communication and adhesion. Such
alterations could involve different pathways. E-cadherin is
part of a multifunctional scaffolding complex playing a key
role in establishing cell polarity in several tissues (Cai and
Mostov 2009). This complex includes proteins such as
IQGAP2 and Cdc42. Interestingly, both IQGAP2-deﬁcient
and Cdc42-deﬁcient mice are highly prone to developing
HCC (Schmidt et al. 2008; van Hengel et al. 2008), thereby
suggesting that alterations in tissue pattern formation are
mechanistically linked to the pathogenesis of neoplastic
disease.
We also analysed the expression of MMP-2 following
transplantation of either normal or nodular hepatocyte in
RS-treated animals. It was found that this enzyme was
mostly expressed at the leading edge of normal hepatocyte
clones, as already reported (Koenig et al. 2005), although
scattered activity could also be detected within DPPIV-
positive clusters. However, the pattern of MMP-2 expres-
sion was different in relation to nodular hepatocyte clusters.
A sharp demarcation could be observed between the
expression of MMP-2protein and expanding nodular lesion.
While the enzyme was expressed in liver tissue surrounding
nodules, virtually no MMP-2 protein could be detected
within such lesions. In addition, a markedly decreased
expression of MMP-2 RNA was present in nodular hepa-
tocytes as compared to normal counterparts. As already
mentioned, MMPs are a family of enzymes that collectively
play fundamental roles in several processes involved in
neoplastic progression, including cell migration and
metastasis (Ellerbroek and Stack 1999). MMPs exist in the
matrix as pro-enzymes and are activated upon proteolytic
cleavage. Unlike other MMPs, the activation of MMP-2
occurs at the cell surface (Montironi et al. 2002), a feature
which confers to this enzyme a central role in cell migra-
tion. It requires the binding of membrane type 1 MMPs
(MT1-MMPs) with the tissue inhibitor of metalloproteinase
type 2 (TIMP2) (Lehti et al. 1998; Nagase et al. 2006).
Native MMP-2 then binds to this complex and this favours
its proteolytic activation by a second MT1-MMP molecule
on the cell membrane. The activity of MMPs is increased
during tumour progression and is associated with invasion
and metastases (Ellerbroek and Stack 1999). Our ﬁndings
indicating low MMP-2 expression in early nodular lesions
are therefore difﬁcult to reconcile with the proposed role of
MMPs in the evolution of neoplastic disease. However, it is
important to point out that early hepatic nodules do not
display any signs of invasive capacity and they are sharply
Histochem Cell Biol (2011) 135:581–591 589
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activity is essential to hepatocyte migration, then its low
expression within nodular hepatocytes might help in
explaining their inability to crawl in between surrounding
hepatocytes and their lack of integration into the host liver,
thereby giving rise to proliferative focal lesions.
In summary, the present study compares the fate of nor-
mal and nodular hepatocytes following orthotopic trans-
plantation into syngeneic host liver pre-conditioned with
RS.Bothcelltypesunderwentselectiveclonalexpansion,as
expected, indicating that growth per se was not a distin-
guishingfeaturebetweenthetwocellpopulations.However,
their growth pattern and biological fates were remarkably
different, and this was associated with altered expression of
DPPIV, Cx32, E-cadherin, and MMP-2 proteins, markers
associated with cell polarity, cell-to-cell communication,
celladhesion,andcellmigration.Weinterprettheseﬁndings
as supporting the concept of a dominant biological pathway
leading to neoplastic disease involving defect(s) in tissue
pattern formation (Feigin and Muthuswamy 2009; Wang
2009; Wodarz and Na ¨thke 2007). Several molecular alter-
ations, other than the ones described in these studies, are
likely to result in a similar phenotype.
Acknowledgments This work was supported by AIRC (Italian
Association for Cancer Research, grant No. 4927 and 10604 to EL).
We thank Anna Saba and Giovanna Porqueddu for their excellent
technical and secretarial assistance.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
Archer KJ, Mas VR, David K, Maluf DG, Bornstein K, Fisher RA
(2009) Identifying genes for establishing a multigenic test for
hepatocellular carcinoma surveillance in hepatitis C virus-
positive cirrhotic patients. Cancer Epidemiol Biomarkers Prev
18:2929–2932
Cai L, Mostov K (2009) Polarity is destiny. Cell 139:660–662
Chen A, Cuevas I, Kenny PA, Miyake H, Mace K, Ghajar C,
Boudreau A, Bissell M, Boudreau N (2009) Endothelial cell
migration and vascular endothelial growth factor expression are
the result of loss of breast tissue polarity. Cancer Res 69:
6721–6729
Clark WR Jr, Elder DE, Guerry D 4th, Epstein MN, Greene MH, Van
Horn M (1984) A study of tumor progression: the precursor
lesions of superﬁcial spreading and nodular melanoma. Hum
Pathol 15:1147–1165
Diallo R, Schaefer KL, Poremba C, Shivazi N, Willmann V, Buerger
H, Dockhorn-Dworniczak B, Boecker W (2001) Monoclonality
in normal epithelium and in hyperplastic and neoplastic lesions
of the breast. J Pathol 193:27–32
Doratiotto S, Marongiu F, Faedda S, Pani P, Laconi E (2009) Altered
growth pattern, not altered growth per se, is the hallmark of early
lesions preceding cancer development. Histol Histopathol 24:
101–106
Ellerbroek SM, Stack MS (1999) Membrane associated matrix
metalloproteinases in metastasis. Bioessays 21:940–949
Feigin ME, Muthuswamy SK (2009) Polarity proteins regulate
mammalian cell-cell junctions and cancer pathogenesis. Curr
Opin Cell Biol 21:694–700
Foulds L (1975) Neoplastic Development, vol 2. Academic Press,
New York, pp 1–15
Fridman R, Toth M, Pen ˜a D, Mobashery S (2009) Activation of
progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res
55:2548–2555
Garcia SB, Novelli M, Wright NA (2000) The clonal origin and
clonal evolution of epithelial tumours. Int J Exp Pathol
81:89–116
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell
100:57–70
Hruban RH, Goggins M, Parsons J, Kern SE (2000) Progression
model for pancreatic cancer. Clin Cancer Res 6:2969–2972
Hytiroglou P, Park Y, Krinsky G, Theise ND (2007) Hepatic
precancerous lesions and small hepatocellular carcinoma. Gas-
troenterol Clin North Am 36:867–887
Iannaccone PM, Weinberg WC, Deamant FD (1987) On the clonal
origin of tumors: a review of experimental models. Int J Cancer
39:778–784
Ihara A, Koizumi H, Hashizume R, Uchikoshi T (1996) Expression of
epithelial cadherin and alpha- and beta-catenins in nontumoral
livers and hepatocellular carcinomas. Hepatology 23:1441–1447
Koenig S, Stoesser C, Krause P, Becker H, Markus PM (2005) Liver
repopulation after hepatocellular transplantation: integration and
interaction of transplanted hepatocytes in the host. Cell Trans-
plant 14:31–40
Kon J, Ichinohe N, Ooe H, Chen Q, Sasaki K, Mitaka T (2009) Thy1-
positive cells have bipotential ability to differentiate into
hepatocytes and biliary epithelial cells in galactosamine-induced
rat liver regeneration. Am J Pathol 175:2362–2371
Kren BT, Kumar NM, Wang SQ, Gilula NB, Steer CJ (1993)
Differential regulation of multiple gap junction transcripts and
proteins during rat liver regeneration. J Cell Biol 123:707–718
Krutovskikh VA, Oyamada M, Yamasaki H (1991) Sequential
changes of gap-junctional intercellular communications during
multistage rat liver carcinogenesis: direct measurement of
communication in vivo. Carcinogenesis 12:1701–1706
Laconi S, Laconi E (2002) Principles of hepatocyte transplantation.
Semin Cell Dev Biol 13:433–438
Laconi S, Curreli F, Diana S, Pasciu D, De Filippo G, Sarma DSR,
Pani P, Laconi E (1999) Liver regeneration in response to partial
hepatectomy in rats treated with retrorsine: a kinetic study.
J Hepatol 31:1069–1074
Laconi S, Pani P, Pillai S, Pasciu D, Sarma DSR, Laconi E (2001a) A
growth constrained environment drives tumor progression in
vivo. Proc Natl Acad Sci USA 98:7806–7811
Laconi S, Pillai S, Porcu PP, Shafritz DA, Pani P, Laconi E (2001b)
Massive liver replacement by transplanted hepatocytes in the
absence of exogenous growth stimuli in rats treated with
retrorsine. Am J Pathol 158:771–777
Lehti K, Lohi J, Valtanen H, Keski-Oja J (1998) Proteolytic
processing of membrane-type-1 matrix metalloproteinase is
associated with gelatinase A activation at the cell surface.
Biochem J 334(Pt 2):345–353
Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M,
Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C,
Mazzaferro V, Bruix J, Waxman S, Friedman SL (2006) A
molecular signature to discriminate dysplastic nodules from
early hepatocellular carcinoma in HCV cirrhosis. Gastroenterol-
ogy 131:1758–1767
590 Histochem Cell Biol (2011) 135:581–591
123Marongiu F, Doratiotto S, Montisci S, Pani P, Laconi E (2008) Liver
repopulation and carcinogenesis: two sides of the same coin?
Am J Pathol 172:857–864
Mason WS, Liu C, Aldrich CE, Litwin S, Yeh MM (2010) Clonal
expansion of normal-appearing human hepatocytes during
chronic hepatitis B virus infection. J Virol 84:8308–8315
Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK
(2001) Changes in WNT/beta-catenin pathway during regulated
growth in rat liver regeneration. Hepatology 33:1098–1109
Montironi R, Mazzucchelli R, Scarpelli M (2002) Precancerous
lesions and conditions of the prostate: from morphological and
biological characterization to chemoprevention. Ann N Y Acad
Sci 963:169–184
Nagase H, Visse R, Murphy G (2006) Structure and function of
matrix metalloproteinases and TIMPs. Cardiovasc Res
69:562–573
Neveu MJ, Hully JR, Babcock KL, Hertzberg EL, Nicholson BJ, Paul
DL, Pitot HC (1994) Multiple mechanisms are responsible for
altered expression of gap junction genes during oncogenesis in
rat liver. J Cell Sci 107(Pt 1):83–95
Noffsinger AE (2009) Serrated polyps and colorectal cancer: new
pathway to malignancy. Annu Rev Pathol 4:343–364
Schmeichel KL, Weaver VM, Bissell MJ (1998) Structural cues from
the tissue microenvironment are essential determinants of the
human mammary epithelial cell phenotype. J Mammary Gland
Biol Neoplasia 3:201–213
Schmidt VA, Chiariello CS, Capilla E, Miller F, Bahou WF (2008)
Development of hepatocellular carcinoma in Iqgap2-deﬁcient
mice is IQGAP1 dependent. Mol Cell Biol 28:1489–1502
Schreer I, Lu ¨ttges J (2005) Precursor lesions of invasive breast cancer.
Eur J Radiol 54:62–71
Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell
Biol 13:29–83
Stecca BA, Nardo B, Chieco P, Mazziotti A, Bolondi L, Cavallari A
(1997) Aberrant dipeptidyl peptidase IV (DPP IV/CD26)
expression in human hepatocellular carcinoma. J Hepatol 27:
337–345
Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P
(1997)Human hepatic preneoplasia: phenotypes andproliferation
kinetics of foci and nodules of altered hepatocytes and their
relationship to liver cell dysplasia. Virchows Arch 431:391–406
Thompson NL, Hixson DC, Callanan H, Panzica M, Flanagan D,
Faria RA, Hong W, Hartel-Schenk S, Doyle DA (1991) Fischer
rat substrain deﬁcient in dipeptidyl peptidase IV activity makes
normal steady-state RNA level and an altered protein: use as a
liver-cell transplantation model. Biochem J 273:497–502
Tretiakova MS, Hart J, Shabani-Rad MT, Zhang J, Gao ZH (2009)
Distinction of hepatocellular adenoma from hepatocellular
carcinoma with and without cirrhosis using E-cadherin and
matrix metalloproteinase immunohistochemistry. Mod Pathol
22:1113–1120
van Hengel J, D’Hooge P, Hooghe B, Wu X, Libbrecht L, De Vos R,
Quondamatteo F, Klempt M, Brakebusch C, van Roy F (2008)
Continuous cell injury promotes hepatic tumorigenesis in cdc42-
deﬁcient mouse liver. Gastroenterology 134:781–792
van Roy F, Berx G (2008) The cell-cell adhesion molecule
E-cadherin. Cell Mol Life Sci 65:3756–3788
Vinken M, Henkens T, De Rop E, Fraczek J, Vanhaecke T, Rogiers V
(2008) Biology and pathobiology of gap junctional channels in
hepatocytes. Hepatology 47:1077–1088
Wang Y (2009) Wnt/Planar cell polarity signaling: a new paradigm
for cancer therapy. Mol Cancer Ther 8:2103–2109
Wodarz A, Na ¨thke I (2007) Cell polarity in development and cancer.
Nat Cell Biol 9:1016–1024
Yamamoto T, Kojima T, Murata M, Takano K, Go M, Hatakeyama
N, Chiba H, Sawada N (2005) p38 MAP-kinase regulates
function of gap and tight junctions during regeneration of rat
hepatocytes. J Hepatol 42:707–718
Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ,
Shi YH, Wu B, Yang GH, Ji Y, Fan J (2010) High expression
levels of putative hepatic stem/progenitor cell biomarkers related
to tumour angiogenesis and poor prognosis of hepatocellular
carcinoma. Gut 59:953–962
Histochem Cell Biol (2011) 135:581–591 591
123